Ann Marie Schmidt

Active 1992–2026

Also published as
Ann‐Marie Schmidt · Ann-Marie Schmidt
237
Papers
60,509
Citations
128
h-index
232
i10-index

Citations

Citations per year for Ann Marie Schmidt1982: 1 citations1993: 4 citations1994: 21 citations1995: 53 citations1996: 75 citations1997: 161 citations1998: 183 citations1999: 271 citations2000: 363 citations2001: 526 citations2002: 480 citations2003: 619 citations2004: 839 citations2005: 888 citations2006: 794 citations2007: 890 citations2008: 934 citations2009: 1,094 citations2010: 978 citations2011: 828 citations2012: 859 citations2013: 804 citations2014: 648 citations2015: 622 citations2016: 512 citations2017: 610 citations2018: 563 citations2019: 1,367 citations2020: 1,648 citations2021: 1,594 citations2022: 1,329 citations2023: 956 citations2024: 1,216 citations2025: 590 citations2026: 7 citations1983–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,517 citing papers, 27.9% of this breakdownChina: 1,829 citing papers, 11.3% of this breakdownUnited Kingdom: 873 citing papers, 5.4% of this breakdownGermany: 862 citing papers, 5.3% of this breakdownItaly: 803 citing papers, 4.9% of this breakdownJapan: 724 citing papers, 4.5% of this breakdownAustralia: 536 citing papers, 3.3% of this breakdownCanada: 498 citing papers, 3.1% of this breakdownIndia: 476 citing papers, 2.9% of this breakdownFrance: 392 citing papers, 2.4% of this breakdownNetherlands: 366 citing papers, 2.3% of this breakdownSouth Korea: 311 citing papers, 1.9% of this breakdown
0%27.9%Other 24.8%

Fields

  • Medicine41.3%
  • Biochemistry, Genetics and Molecular Biology39.6%
  • Immunology and Microbiology5.7%
  • Neuroscience5.4%
  • Dentistry3.2%
  • Nursing0.8%
  • Other4%

Topics

  • Advanced Glycation End Products research9.9%
  • Alzheimer's disease research and treatments4.9%
  • Neuroinflammation and Neurodegeneration Mechanisms2.3%
  • S100 Proteins and Annexins2.3%
  • Natural Antidiabetic Agents Studies2.1%
  • Immune Response and Inflammation1.6%
  • Other76.9%

Coauthors

All papers

Open in search
  1. Advanced Glycation End Products

    Authors: , , , - Circulation 2006 cited by 2,227

  2. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2003 cited by 1,397

  3. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

    Authors: , , , , , , , , , , , , , - Nature 1996 cited by 2,003

  4. RAGE Mediates a Novel Proinflammatory Axis

    Authors: , , , , , , , , , , , , , , , , , - Cell 1999 cited by 1,858

  5. Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis

    Authors: , , , , , , , , , , , , , , - Cell Metabolism 2013 cited by 576

  6. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

    Authors: , , , , , - American Journal of Physiology-Endocrinology and Metabolism 2001 cited by 1,054

  7. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

    Authors: , , - Annals of the New York Academy of Sciences 2011 cited by 514

  8. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Bakker, Anthony Lubinsky, Deepak Pradhan, Daniel H. Sterman, Michael D. Weiden, Adriana Heguy, Laura Evans, Timothy M. Uyeki, José C. Clemente, Emmie de Wit, Ann Marie Schmidt, Bo Shopsin, Ludovic Desvignes, Chan Wang, Huilin Li, Bin Zhang, Christian V. Forst, Shohei Koide, Kenneth A. Stapleford, Kamal M. Khanna, Elodie Ghedin, Leopoldo N. Segal - Nature Microbiology 2021 cited by 196

  9. Diabetes Mellitus and Cardiovascular Disease

    Authors: - Arteriosclerosis Thrombosis and Vascular Biology 2019 cited by 180

  10. Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42

    Authors: , , , , , , - Journal of Biological Chemistry 2008 cited by 349

  11. Highlighting Diabetes Mellitus

    Authors: - Arteriosclerosis Thrombosis and Vascular Biology 2017 cited by 295

  12. RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , - The FASEB Journal 2009 cited by 325

  13. Endothelial cells in physiology and in the pathophysiology of vascular disorders.

    Authors: , , , , , , , , , , , , , , - 1998 cited by 2,261

  14. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

    Authors: , , , , , , , , - Journal of Biological Chemistry 1992 cited by 1,531

  15. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

    Authors: , , , , , , , , , , , , - Journal of Biological Chemistry 1995 cited by 1,143

  16. Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease

    Authors: , , - Endocrinology 2019 cited by 181

  17. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus

    Authors: , , , , , , , , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2020 cited by 94

  18. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

    Authors: , , , - Journal of Clinical Investigation 2001 cited by 1,117

  19. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

    Authors: , , , , , - Glycobiology 2005 cited by 826

  20. Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB

    Authors: , , , , , , , , , , , , , , , , , , , , , - Diabetes 2001 cited by 818

  21. Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications

    Authors: , , , , - Frontiers in Endocrinology 2021 cited by 101

  22. The IRG1–itaconate axis protects from cholesterol-induced inflammation and atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2024 cited by 67

  23. DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stress

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 51

  24. Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology

    Authors: , , , , , , , , , , - Journal of Diabetes Research 2015 cited by 255